286
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

The Metabolic Characteristics of Patients at the Risk for Diabetic Foot Ulcer: A Comparative Study of Diabetic Patients with and without Diabetic Foot

, ORCID Icon, ORCID Icon, , , , , , & show all
Pages 3197-3211 | Received 13 Jul 2023, Accepted 27 Sep 2023, Published online: 17 Oct 2023

References

  • van Netten JJ, Bus SA, Apelqvist J, et al. Definitions and criteria for diabetic foot disease. Diabetes Metab Res Rev. 2020;36(Suppl 1):e3268. doi:10.1002/dmrr.3268
  • McDermott K, Fang M, Boulton AJM, Selvin E, Hicks CW. Etiology, epidemiology, and disparities in the burden of diabetic foot ulcers. Diabetes Care. 2023;46(1):209–221. doi:10.2337/dci22-0043
  • International Diabetes Federation. The Diabetic Foot. Brussels, Belgium: International Diabetes Federation; 2020.
  • Society CD. Chinese guidelines for the prevention and treatment of type 2 diabetes (2020). Chin J Pract Inter Med. 2021;41(09):668–784.
  • Wang YZ, Wang AH, Zhao S, et al. 中国南方与北方地区糖尿病足病危险因素分析 [Differences in risk factors of diabetic foot in the patients in South and North China]. Zhonghua Yi Xue Za Zhi. 2007;87(26):1817–1820. Chinese.
  • ElSayed NA, Aleppo G, Aroda VR, et al. 12. Retinopathy, neuropathy, and foot care: standards of care in diabetes-2023. Diabetes Care. 2023;46(Suppl 1):S203–S215. doi:10.2337/dc23-S012
  • Fu XL, Ding H, Miao WW, Mao CX, Zhan MQ, Chen HL. Global recurrence rates in diabetic foot ulcers: a systematic review and meta-analysis. Diabetes Metab Res Rev. 2019;35(6):e3160. doi:10.1002/dmrr.3160
  • Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis (†). Ann Med. 2017;49(2):106–116. doi:10.1080/07853890.2016.1231932
  • Armstrong DG, Boulton AJM, Bus SA, Ingelfinger JR. Diabetic foot ulcers and their recurrence. N Engl J Med. 2017;376(24):2367–2375. doi:10.1056/NEJMra1615439
  • Soyoye DO, Abiodun OO, Ikem RT, Kolawole BA, Akintomide AO. Diabetes and peripheral artery disease: a review. World J Diabetes. 2021;12(6):827–838. doi:10.4239/wjd.v12.i6.827
  • Lechleitner M, Abrahamian H, Francesconi C, Kofler M, Sturm W, Köhler G. Diabetische Neuropathie und diabetischer Fuß (Update 2019) [Diabetic neuropathy and diabetic foot syndrome (Update 2019)]. Wien Klin Wochenschr. 2019;131(Suppl 1):141–150. German. doi:10.1007/s00508-019-1487-4
  • Lazzarini PA, Cramb SM, Golledge J, Morton JI, Magliano DJ, Van Netten JJ. Global trends in the incidence of hospital admissions for diabetes-related foot disease and amputations: a review of national rates in the 21st century. Diabetologia. 2023;66(2):267–287. doi:10.1007/s00125-022-05845-9
  • Ezzatvar Y, García-Hermoso A. Global estimates of diabetes-related amputations incidence in 2010–2020: a systematic review and meta-analysis. Diabetes Res Clin Pract. 2023;195:110194. doi:10.1016/j.diabres.2022.110194
  • Armstrong DG, Tan TW, Boulton AJM, Bus SA. Diabetic Foot Ulcers: a Review. JAMA. 2023;330(1):62–75. doi:10.1001/jama.2023.10578
  • Yang L, Rong GC, Wu QN. Diabetic foot ulcer: challenges and future. World J Diabetes. 2022;13(12):1014–1034. doi:10.4239/wjd.v13.i12.1014
  • Naemi R, Balasubramanian G, Darvel T, Chockalingam N. Predicting diabetic foot ulceration using routinely collected data in a foot clinic. What level of prognostic accuracy can be achieved? Diabetes Metab Res Rev. 2023;39(6):e3674. doi:10.1002/dmrr.3674
  • Kaka AS, Landsteiner A, Ensrud KE, et al. Risk prediction models for diabetic foot ulcer development or amputation: a review of reviews. J Foot Ankle Res. 2023;16(1):13. doi:10.1186/s13047-023-00610-6
  • Wang M, Chen D, Fu H, et al. Development and validation of a risk prediction model for the recurrence of foot ulcer in type 2 diabetes in China: a longitudinal cohort study based on a systematic review and meta-analysis. Diabetes Metab Res Rev. 2023;39(4):e3616. doi:10.1002/dmrr.3616
  • Peng B, Min R. Development of predictive nomograms clinical use to quantify the risk of diabetic foot in patients with type 2 diabetes mellitus. Front Endocrinol. 2023;14:1186992. doi:10.3389/fendo.2023.1186992
  • Shao Z, Wang Z, Bi S, Zhang J. Establishment and validation of a nomogram for progression to diabetic foot ulcers in elderly diabetic patients. Front Endocrinol. 2023;14:1107830. doi:10.3389/fendo.2023.1107830
  • ElSayed NA, Aleppo G, Aroda VR, et al. 2. Classification and diagnosis of diabetes: standards of care in diabetes-2023. Diabetes Care. 2023;46(Suppl 1):S19–S40. doi:10.2337/dc23-S002
  • Das SK, Roy P, Singh P, et al. Diabetic foot ulcer identification: a review. Diagnostics. 2023;13(12). doi:10.3390/diagnostics13121998
  • Smith S, Normahani P, Lane T, Hohenschurz-Schmidt D, Oliver N, Davies AH. Prevention and management strategies for diabetic neuropathy. Life. 2022;12(8):1185.
  • Joseph S, Munshi B, Agarini R, Kwok RCH, Green DJ, Jansen S. Near infrared spectroscopy in peripheral artery disease and the diabetic foot: a systematic review. Diabetes Metab Res Rev. 2022;38(7):e3571. doi:10.1002/dmrr.3571
  • Wang X, Yuan CX, Xu B, Yu Z. Diabetic foot ulcers: classification, risk factors and management. World J Diabetes. 2022;13(12):1049–1065. doi:10.4239/wjd.v13.i12.1049
  • Rajab AAH, Hegazy WAH. What’s old is new again: insights into diabetic foot microbiome. World J Diabetes. 2023;14(6):680–704. doi:10.4239/wjd.v14.i6.680
  • Kurze C, Farn CJ, Siow J. The interdisciplinary approach: preventive and therapeutic strategies for diabetic foot ulcers. Foot Ankle Clin. 2022;27(3):529–543. doi:10.1016/j.fcl.2022.03.001
  • Ramsey DJ, Kwan JT, Sharma A. Keeping an eye on the diabetic foot: the connection between diabetic eye disease and wound healing in the lower extremity. World J Diabetes. 2022;13(12):1035–1048. doi:10.4239/wjd.v13.i12.1035
  • Werkman NCC, Driessen JHM, Stehouwer CDA, et al. The use of sodium-glucose co-transporter-2 inhibitors or glucagon-like peptide-1 receptor agonists versus sulfonylureas and the risk of lower limb amputations: a nation-wide cohort study. Cardiovasc Diabetol. 2023;22(1):160. doi:10.1186/s12933-023-01897-2
  • Lu Y, Guo C. Risk of lower limb amputation in diabetic patients using SGLT2 inhibitors versus DPP4 inhibitors or GLP-1 agonists: a meta-analysis of 2 million patients. Ther Adv Drug Saf. 2023;14:20420986231178126. doi:10.1177/20420986231178126
  • Caruso P, Maiorino MI, Bellastella G, Esposito K, Giugliano D. Pleiotropic effects of GLP-1 receptor agonists on peripheral artery disease: is there any hope? Diabetes Metab Res Rev. 2023;39(7):e3627. doi:10.1002/dmrr.3627
  • Shao S, Zhang X, Xu Q, Pan R, Chen Y. Emerging roles of Glucagon like peptide-1 in the management of autoimmune diseases and diabetes-associated comorbidities. Pharmacol Ther. 2022;239:108270. doi:10.1016/j.pharmthera.2022.108270
  • Nurmohamed NS, Kraaijenhof JM, Stroes ESG. Lp(a): a new pathway to target? Curr Atheroscler Rep. 2022;24(11):831–838. doi:10.1007/s11883-022-01060-4
  • Berberich AJ, Hegele RA. A modern approach to dyslipidemia. Endocr Rev. 2022;43(4):611–653. doi:10.1210/endrev/bnab037
  • Ulloque-Badaracco JR, Mosquera-Rojas MD, Hernandez-Bustamante EA, et al. Association between lipid profile and apolipoproteins with risk of diabetic foot ulcer: a systematic review and meta-analysis. Int J Clin Pract. 2022;2022:5450173. doi:10.1155/2022/5450173
  • Vlad LG, Grosser JA, Dodenhoff KA, Peoples AE, Aguilo-Seara G, Molnar JA. Examining albumin as a bioindicator of healing capability in patients with diabetic foot ulcers: a retrospective review. Wounds. 2023;35(6):E193–e196. doi:10.25270/wnds/23012
  • Wang Y, Liu B, Pi Y, et al. Risk factors for diabetic foot ulcers mortality and novel negative pressure combined with platelet-rich plasma therapy in the treatment of diabetic foot ulcers. Front Pharmacol. 2022;13:1051299. doi:10.3389/fphar.2022.1051299
  • Lewis S, Raj D, Guzman NJ. Renal failure: implications of chronic kidney disease in the management of the diabetic foot. Semin Vasc Surg. 2012;25(2):82–88. doi:10.1053/j.semvascsurg.2012.04.007
  • Kaminski MR, Raspovic A, McMahon LP, et al. Risk factors for foot ulceration and lower extremity amputation in adults with end-stage renal disease on dialysis: a systematic review and meta-analysis. Nephrol Dial Transplant. 2015;30(10):1747–1766. doi:10.1093/ndt/gfv114
  • Tran SK, Carr JB, Hall MJ, Park JS, Cooper MT. Incidence of thyroid disease in patients with forefoot deformity. Foot Ankle Surg. 2020;26(4):445–448. doi:10.1016/j.fas.2019.05.014
  • Yammine K, Hayek F, Assi C. Is there an association between anemia and diabetic foot ulcers? A systematic review and meta-analysis. Wound Repair Regen. 2021;29(3):432–442. doi:10.1111/wrr.12902
  • Yan P, Zhang Z, Miao Y, Xu Y, Zhu J, Wan Q. Physiological serum total bilirubin concentrations were inversely associated with diabetic peripheral neuropathy in Chinese patients with type 2 diabetes: a cross-sectional study. Diabetol Metab Syndr. 2019;11(1):100. doi:10.1186/s13098-019-0498-7
  • Alqahtani N, Ghazwani EY, Al-Qahtani AM, Elmahboub RA. Correlation of iron levels with glycemia and microvascular complications among type II diabetes mellitus patients in Najran university hospital. J Fam Med Prim Care. 2022;11(6):2690–2694. doi:10.4103/jfmpc.jfmpc_545_21
  • Reddy S, Anoop S, Jebasingh FK, et al. Differentials in dietary intake of macro and micronutrients in patients with type 2 diabetes and foot ulcers: observations from a pilot study. Clin Nutr ESPEN. 2022;47:170–176. doi:10.1016/j.clnesp.2021.12.023
  • Kulprachakarn K, Ounjaijean S, Wungrath J, Mani R, Rerkasem K. Micronutrients and natural compounds status and their effects on wound healing in the diabetic foot ulcer. Int J Low Extrem Wounds. 2017;16(4):244–250. doi:10.1177/1534734617737659
  • Hong J, Liu WY, Hu X, et al. Free triiodothyronine and free triiodothyronine to free thyroxine ratio predict all-cause mortality in patients with diabetic foot ulcers. Diabetes Metab Syndr Obes. 2022;15:467–476. doi:10.2147/DMSO.S354754
  • Perlstein TS, Pande RL, Beckman JA, Creager MA. Serum total bilirubin level and prevalent lower-extremity peripheral arterial disease: national Health and Nutrition Examination Survey (NHANES) 1999 to 2004. Arterioscler Thromb Vasc Biol. 2008;28(1):166–172. doi:10.1161/ATVBAHA.107.153262
  • Lan Y, Liu H, Liu J, Zhao H, Wang H. The relationship between serum bilirubin levels and peripheral arterial disease and gender difference in patients with hypertension: BEST study. Angiology. 2020;71(4):340–348. doi:10.1177/0003319719900734
  • Ozeki M, Morita H, Miyamura M, et al. High serum bilirubin is associated with lower prevalence of peripheral arterial disease among cardiac patients. Clin Chim Acta. 2018;476:60–66. doi:10.1016/j.cca.2017.11.013
  • Kim ES, Mo EY, Moon SD, Han JH, Catapano A. Inverse association between serum bilirubin levels and arterial stiffness in Korean women with type 2 diabetes. PLoS One. 2014;9(10):e109251. doi:10.1371/journal.pone.0109251
  • Inoguchi T, Sonoda N, Maeda Y. Bilirubin as an important physiological modulator of oxidative stress and chronic inflammation in metabolic syndrome and diabetes: a new aspect on old molecule. Diabetol Int. 2016;7(4):338–341. doi:10.1007/s13340-016-0288-5
  • Zhao CC, Wang JW, Chen MY, Ke JF, Li MF, Li LX. High-normal serum bilirubin decreased the risk of lower limb atherosclerosis in type 2 diabetes: a real-world study. Diabetol Metab Syndr. 2023;15(1):105. doi:10.1186/s13098-023-01088-9
  • Mayer M. Association of serum bilirubin concentration with risk of coronary artery disease. Clin Chem. 2000;46(11):1723–1727. doi:10.1093/clinchem/46.11.1723
  • Kipp ZA, Xu M, Bates EA, Lee WH, Kern PA, Hinds TD. Bilirubin levels are negatively correlated with adiposity in obese men and women, and its catabolized product, urobilin, is positively associated with insulin resistance. Antioxidants. 2023;12(1):170. doi:10.3390/antiox12010170
  • Wang P, Shao X, Bao Y, et al. Impact of obese levels on the hepatic expression of nuclear receptors and drug-metabolizing enzymes in adult and offspring mice. Acta Pharm Sin B. 2020;10(1):171–185. doi:10.1016/j.apsb.2019.10.009
  • Stec DE, John K, Trabbic CJ, et al. Bilirubin binding to PPARα inhibits lipid accumulation. PLoS One. 2016;11(4):e0153427. doi:10.1371/journal.pone.0153427
  • Woronyczová J, Nováková M, Leníček M, et al. Serum bilirubin concentrations and the prevalence of gilbert syndrome in elite athletes. Sports Med. 2022;8(1):84.
  • Xu MR, Jin CH, Lu JX, Li MF, Li LX. High-normal unconjugated bilirubin is associated with decreased risk of chronic kidney disease in type 2 diabetes: a real-world study. Diabetes Metab Res Rev. 2023;39(6):e3672. doi:10.1002/dmrr.3672
  • Tafese R, Genet S, Addisu S. Association of serum total bilirubin and uric acid with low glomerular filtration rate diabetic kidney disease in type 2 diabetic patients. Diabetes Metab Syndr Obes. 2022;15:3993–3999. doi:10.2147/DMSO.S391777
  • Li S, Li N, Li L, et al. Association of serum bilirubin levels with macro- and microvascular complications in Chinese people with type 2 diabetes mellitus: new insight on gender differences. Diabetes Metab Syndr Obes. 2023;16:597–606. doi:10.2147/DMSO.S403483
  • Kurian SJ, Baral T, Unnikrishnan MK, et al. The association between micronutrient levels and diabetic foot ulcer: a systematic review with meta-analysis. Front Endocrinol. 2023;14:1152854. doi:10.3389/fendo.2023.1152854
  • Leal EC, Carvalho E. Heme Oxygenase-1 as therapeutic target for diabetic foot ulcers. Int J Mol Sci. 2022;23(19). doi:10.3390/ijms231912043
  • Deng H, Li B, Shen Q, et al. Mechanisms of diabetic foot ulceration: a review. J Diabetes. 2023;15(4):299–312. doi:10.1111/1753-0407.13372
  • Kosacka J, Woidt K, Toyka KV, et al. The role of dietary non-heme iron load and peripheral nerve inflammation in the development of peripheral neuropathy (PN) in obese non-diabetic leptin-deficient ob/ob mice. Neurol Res. 2019;41(4):341–353. doi:10.1080/01616412.2018.1564191
  • Xu C, Gong M, Wen S, Zhou M, Li Y, Zhou L. The comparative study on the status of bone metabolism and thyroid function in diabetic patients with or without ketosis or ketoacidosis. Diabetes Metab Syndr Obes. 2022;15:779–797. doi:10.2147/DMSO.S349769
  • Gong M, Xu C, Wen S, et al. The effects of obesity on bone turnover markers in diabetic patients with diabetic ketosis or ketoacidosis. Endocr Metab Immune Disord Drug Targets. 2023. doi:10.2174/1871530323666230509101203
  • Iwamoto Y, Kimura T, Tatsumi F, et al. Effect of hyperglycemia-related acute metabolic disturbance on thyroid function parameters in adults. Front Endocrinol. 2022;13:869869. doi:10.3389/fendo.2022.869869
  • Ranuve MS, Mohammadnezhad M. Healthcare workers’ perceptions on diabetic foot ulcers (DFU) and foot care in Fiji: a qualitative study. BMJ open. 2022;12(8):e060896. doi:10.1136/bmjopen-2022-060896
  • Kuhnke JL, Keast D, Rosenthal S, Evans RJ. Health professionals’ perspectives on delivering patient-focused wound management: a qualitative study. J Wound Care. 2019;28(Sup7):S4–S13. doi:10.12968/jowc.2019.28.Sup7.S4
  • Lo ZJ, Tan E, Chandrasekar S, et al. Diabetic foot in primary and tertiary (DEFINITE) Care: a health services innovation in coordination of diabetic foot ulcer (DFU) Care within a healthcare cluster - 18-month results from an observational population health cohort study. Int Wound J. 2023;20(5):1609–1621. doi:10.1111/iwj.14016